This study compared the efficiency and safety of radiotherapy plus erlotinib with concurrent
chemoradiotherapy (CCRT) based on paclitaxel plus cisplatin in elderly esophageal cancer …

Purpose: Elderly patients with esophageal cancer who are not candidates for
chemoradiation may benefit from targeted agents; hence erlotinib combined with …

Objective To evaluate the safety and efficacy of radiation plus erlotinib in patients with
esophageal cancer older than 70 years. Methods Radiotherapy was prescribed at a daily …

Background: Neoadjuvant chemoradiotherapy (CRT) followed by an esophagectomy is the
standard treatment for locally advanced esophageal cancer, but remains a great challenge …

Background/Aim: To determine whether concurrent chemotherapy with radiotherapy should
be performed in elderly patients with esophageal cancer. Patients and Methods: A total of …

Introduction Radiotherapy (RT) is the main treatment for unoperated esophageal cancer
(EC) patients. It is controversial whether adding chemotherapy (CT) to RT is beneficial for …

Introduction: Esophageal adenocarcinoma (EC) is increasing in incidence. Chemoradiation
(CRT) is regarded as an acceptable alternative to surgery for the management of locally …

Importance Most older patients with esophageal cancer cannot complete the standard
concurrent chemoradiotherapy (CCRT). An effective and tolerable chemoradiotherapy …

The most relevant treatment modalities in elderly patients with esophageal carcinoma (EC)
remain a subject of debate. Combined definitive chemoradiotherapy (CRT) is currently …

Objective This study aimed at assessing the efficiency and safety of concurrent
chemoradiotherapy (CCRT) using paclitaxel (PTX) plus cisplatin (CDDP) in elderly (age≥ …